Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 25 04:00PM ET
122.18
Dollar change
+0.21
Percentage change
0.17
%
IndexS&P 500 P/E37.38 EPS (ttm)3.27 Insider Own23.84% Shs Outstand888.23M Perf Week7.16%
Market Cap108.53B Forward P/E16.84 EPS next Y7.25 Insider Trans-9.24% Shs Float676.50M Perf Month-6.87%
Income3.08B PEG1.72 EPS next Q1.22 Inst Own60.92% Short Float1.42% Perf Quarter-14.87%
Sales23.38B P/S4.64 EPS this Y22.82% Inst Trans-0.04% Short Ratio1.84 Perf Half Y-8.29%
Book/sh26.63 P/B4.59 EPS next Y25.68% ROA0.91% Short Interest9.58M Perf Year20.21%
Cash/sh17.30 P/C7.06 EPS next 5Y21.79% ROE13.23% 52W Range91.92 - 170.40 Perf YTD-17.40%
Dividend Est.0.75 (0.61%) P/FCF15.06 EPS past 5Y-1.51% ROI4.15% 52W High-28.30% Beta1.76
Dividend TTM0.70 (0.57%) Quick Ratio- Sales past 5Y117.00% Gross Margin36.58% 52W Low32.92% ATR (14)5.34
Dividend Ex-DateFeb 14, 2025 Current Ratio- EPS Y/Y TTM-18.20% Oper. Margin20.15% RSI (14)47.27 Volatility3.09% 4.42%
Employees4834 Debt/Eq2.16 Sales Y/Y TTM42.19% Profit Margin13.16% Recom1.50 Target Price170.17
Option/ShortYes / Yes LT Debt/Eq2.14 EPS Q/Q3.17% Payout21.06% Rel Volume0.76 Prev Close121.97
Sales Surprise2.51% EPS Surprise3.33% Sales Q/Q-53.10% EarningsFeb 04 BMO Avg Volume5.20M Price122.18
SMA202.29% SMA50-11.46% SMA200-7.67% Trades Volume3,954,925 Change0.17%
Date Action Analyst Rating Change Price Target Change
Mar-20-25Upgrade Wells Fargo Equal Weight → Overweight $150 → $141
Jan-30-25Downgrade HSBC Securities Buy → Hold $173
Sep-18-24Initiated HSBC Securities Buy $148
Sep-12-24Initiated Wells Fargo Equal Weight $130
Aug-27-24Initiated Redburn Atlantic Buy $153
Jan-04-24Initiated TD Cowen Outperform $96
Nov-30-23Reiterated Oppenheimer Outperform $91 → $94
Oct-05-23Initiated Wolfe Research Outperform $75
May-19-23Initiated Citigroup Buy $69
Mar-02-23Initiated Barclays Overweight $69
Today 08:59PM
02:10AM
Mar-24-25 04:15PM
Mar-22-25 03:14PM
11:35AM
08:48AM Loading…
Mar-21-25 08:48AM
Mar-20-25 08:01PM
09:20AM
Mar-17-25 08:49AM
Mar-13-25 04:30PM
Mar-06-25 11:31AM
10:33AM
12:56AM
Mar-05-25 07:43PM
05:08PM
01:43PM Loading…
01:43PM
12:12PM
11:47AM
06:04AM
04:06AM
12:10AM
Mar-04-25 11:41PM
05:05PM
08:57AM
07:09AM
Mar-03-25 05:15AM
Mar-02-25 05:02PM
02:21PM
10:01AM
Feb-27-25 03:58AM
04:15PM Loading…
Feb-26-25 04:15PM
11:32AM
Feb-25-25 11:48AM
03:09AM
Feb-24-25 06:21AM
Feb-23-25 09:17PM
06:18PM
10:34AM
Feb-21-25 07:55PM
02:10AM
Feb-20-25 10:14PM
12:00PM
10:05AM
04:44AM
12:53AM
12:35AM
12:18AM
Feb-19-25 09:58AM
08:15AM
Feb-18-25 08:45AM
02:46AM
Feb-17-25 05:03PM
05:01AM
03:24AM
Feb-16-25 11:15PM
05:55PM
05:30AM
Feb-14-25 07:15AM
06:00AM
Feb-13-25 05:05PM
06:49AM
Feb-12-25 05:00PM
Feb-11-25 06:34PM
05:23PM
12:40PM
11:52AM
Feb-10-25 07:44PM
04:15PM
04:12AM
Feb-07-25 11:03AM
09:15AM
Feb-06-25 03:44PM
10:02AM
09:50AM
04:35AM
Feb-05-25 04:30PM
08:00AM
02:56AM
02:12AM
Feb-04-25 04:34PM
04:29PM
12:26PM
11:51AM
10:33AM
10:30AM
09:11AM
09:09AM
08:58AM
06:58AM
06:50AM
01:53AM
12:02AM
Feb-01-25 08:03AM
Jan-31-25 09:15AM
Jan-29-25 10:31AM
09:04AM
08:04AM
04:00AM
Jan-28-25 04:15PM
Jan-27-25 04:15PM
KKR & Co., Inc. operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities. The Insurance Business segment offers retirement, life insurance and reinsurance solutions to clients across individual and institutional markets. The company was founded by Henry Kravis, George R. Roberts, and Jerome Kholberg on May 1, 1976 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KKR Group Partnership L.P.10% OwnerMar 10 '25Sale9.912,948,72329,221,8450Mar 11 07:19 PM
KKR Genetic Disorder L.P.10% OwnerMar 05 '25Sale32.966,000,000197,760,00019,260,971Mar 07 06:09 PM
KKR Group Partnership L.P.10% OwnerNov 27 '24Sale29.99956,46228,686,6870Nov 29 01:33 PM
KKR Group Partnership L.P.10% OwnerNov 21 '24Sale309.975,274,2461,634,860,90968,037Nov 25 04:30 PM
KKR Group Partnership L.P.10% OwnerNov 18 '24Sale29.996,376,411191,244,5070Nov 18 09:22 PM
KKR Genetic Disorder L.P.10% OwnerSep 13 '24Sale25.755,800,000149,350,00025,260,971Sep 17 06:44 PM
KKR Group Partnership L.P.10% OwnerSep 11 '24Buy11.1311,619,998129,330,57892,959,984Sep 13 04:44 PM
KKR Group Partnership L.P.10% OwnerJul 25 '24Sale18.852,554,64448,155,0390Jul 29 06:33 PM
KKR Phorm Investors L.P.10% OwnerJun 20 '24Sale5.1024,411,968124,501,0370Jun 20 04:30 PM
KKR Alternative Assets LLC10% OwnerJun 04 '24Buy25.561,956,18250,000,0009,688,618Jun 06 09:02 PM
KKR Group Partnership L.P.10% OwnerMay 23 '24Sale12.4817,500,000218,400,00033,133,123May 28 06:08 PM
KKR Group Partnership L.P.10% OwnerMay 13 '24Sale83.3617,500,0001,458,800,000366,567May 15 05:25 PM
KKR Group Partnership L.P.10% OwnerApr 01 '24Sale10.746,000,00064,440,0000Apr 03 06:21 PM
KKR Alternative Assets LLC10% OwnerMar 26 '24Buy25.00571,42914,285,7141,000,687Mar 28 04:33 PM